| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.54 | 0.05 |